A Dose-escalation Study of LUNA18 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).

NCT05012618 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

128

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decided to discontinue this study upon having LPLV.

Conditions

Locally Advanced or Metastatic Solid Tumors

Interventions

DRUG: LUNA18
DRUG: Cetuximab

Sponsor

Chugai Pharmaceutical